Dominique Valla

Five‐year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence

D. Valla, P. Batel, F. Pessione, 2003, Liver international : official journal of the International Association for the Study of the Liver.

Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation

V. Paradis, V. Vilgrain, D. Valla, 2005, Gut.

Prospective direct comparison of non‐invasive liver tests in outpatients with type 2 diabetes using intention‐to‐diagnose analysis

V. Paradis, P. Bedossa, S. Pol, 2023, Alimentary pharmacology & therapeutics.

Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma.

V. Vilgrain, O. Farges, D. Valla, 2001, Journal of hepatology.

A new NRF2 activator for the treatment of human metabolic dysfunction-associated fatty liver disease

P. Delerive, S. Laouirem, M. Albuquerque, 2023, JHEP reports : innovation in hepatology.

Hepatic nodules in Budd-Chiari syndrome: imaging features.

V. Vilgrain, D. Valla, J. Belghiti, 1999, Radiology.

Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factors

V. de Lédinghen, D. Roulot, R. Borie, 2023, Hepatology.

Quantitative gene expression in Budd-Chiari syndrome: a molecular approach to the pathogenesis of the disease

M. Vidaud, I. Laurendeau, D. Dargère, 2005, Gut.

Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies.

A. Nuzzo, J. García‐Pagán, M. Senzolo, 2024, The lancet. Gastroenterology & hepatology.